INTRODUCTION 1
Hypoplastic left heart syndrome (HLHS) is a congenital heart disease (CHD) 2 characterized by underdevelopment of the left ventricle, mitral and aortic valves, and aortic arch. 3 Variable phenotypic manifestations and familial inheritance patterns, together with the numerous 4 studies linking it to a diverse array of genes, [1] [2] [3] [4] suggest that HLHS is genetically heterogeneous 5 and may have significant environmental contributors. In this scenario, synergistic combinations 6 of filtering and validation approaches are necessary to prioritize candidate genes and gene 7 variants that may affect cardiogenic pathways throughout the dynamic process of human heart 8 development. 9 Although the cellular mechanisms causing HLHS remain poorly characterized, a recent 1 0 study reported generation of the first animal model of HLHS. Based on a digenic mechanism, prematurely at 29 weeks gestation and underwent staged surgical palliation at 2 and 11 months 1 of age. Conversion to a fenestrated Fontan circulation at 3 years of age failed owing to systolic 2 and diastolic heart failure, necessitating early take-down. The patient subsequently died of multi-3 organ system failure. Echocardiography revealed structurally and functionally normal hearts in 4 the proband's mother (I.2), father (I.1) and siblings (II.1 and II.2). Maternal history is notable for 5 4 miscarriages. 6 Patient-derived iPSCs are a valuable tool to investigate heart defects, such as those 7 observed in HLHS. 3, 25 In this study, iPSCs from the mother (I.2), father (I.1) and HLHS proband 8 (II.3) were generated 26 to investigate differences in transcriptional profiles potentially associated 9 with HLHS, cells from the proband-parent trio were differentiated to day 25, using a cardiogenic 1 0 differentiation protocol and processed for subsequent RNA sequencing ( Figure 1B ). In this in 1 1 vitro cellular context, bioinformatic analysis revealed that 5,104 differentially expressed 1 2 transcripts (DETs) in D25 differentiated samples between proband vs. mother/father (Online 1 3 Table 1 , Benjamini-corrected p<0.001). We found that 1,401 DETs were concordantly Online Table 1 and 2). Consistent with previous observations in HLHS fetuses, 6 KEGG analysis 1 6 revealed TP53 pathway enrichment ( Figure 1D ), including cell cycle inhibition ( Figure 1E ), 1 7
suggesting that cell proliferation may be affected in proband cells.
8
To test this hypothesis, we measured cell cycle activity in proband and parent hiPSC- Family-based WGS, variant filtering, and transcriptional profiling identified 10 candidates 5 Array comparative genome hybridization ruled out a chromosomal deletion or 6 duplication in the proband. WGS was performed to identify potentially pathogenic coding or 7 regulatory single nucleotide variants (SNVs) or insertion/deletions (INDELs). Variants were 8 filtered for rarity, predicted impact on protein strucuture or expression, and de novo or recessive 9 inheritance, yielding 114 variants in 61 genes (Figure 2, Online Table 3 ). We next prioritized 1 0 genes most likely to drive downstream pathways of dysregulated cardiogenesis in the HLHS 1 1 proband by cross-referencing these candidate genes with 3,816 DETs identified in 1 2 undifferentiated iPSC at day 0 (d0) (Online Table 4 ) and 5,104 DETs identified at day 25 (d25) 1 3 differentiated cell lineages (Online Table 1 ). Ten genes harboring recessive variants were 1 4 differentially expressed within the HLHS proband's iPSCs at d0 and d25: HSPG2, APOB, LRP2, 1 5 PRTG, SLC9A1, SDHD, JPT1, ELF4, HS6ST2 and SIK1 ( Figure 2 ). In order to determine whether these variants occured within genes that could be important 1 9
for cardiac differentiation in vivo, we took advantage of our established Drosophila heart 2 0 development model and functional analysis tools ( Figure 3A ). 14 We hypothesized that genes 2 1 critical for the Drosophila heart have conserved roles also in humans, as previously observed 19, 2 2 20, 27 . Predicted by DIOPT database 22 to have orthologs in Drosophila ( Figure 3B ), we analyzed 9 1 0 genes using heart-specific RNAi KD. By in vivo heart structure and function analysis, 13 we found 1 that KD of LRP2 (mgl), and APOB (apolpp) resulted in arrhythmias ( Figure 3C ,D, E; Online 2 movies S1, S2, S3). KD of JPT1 (CG1943) resulted in dilation, suggesting a developmental or 3 remodeling defect ( Figure 3F ).
4
Since HLHS is likely oligogenic, 28, 29 some genes in HLHS might only become apparent 5 in combination with mutations in other cardiac-relevant genes. To test this, we examined the 6 candidates also in the heterozygous background for tinman/NKX2-5, which in humans is well-7 known to contribute to a variety of CHD/HLHS manifestations. 1, 25, 30, 31 In this in vivo context, 8 heart-specific knockdown of 2 out of 9 genes, namely HSPG2/Perlecan (trol), involved in 9 extracellular matrix assembly, 32 and the SDHD (SdhD), exhibited a constricted phenotype 1 0 ( Figure 3G ,H). These findings demonstrate that our bioinformatic candidate gene prioritization 1 1 identified several candidates as cardiac relevant. Decreased proliferation of left ventricular cardiomyocytes is a phenotypic hallmark of 1 5 HLHS; 5, 6 see Figure 1G ), suggesting that cell cycle impairment likely contributes to the disease.
6
Thus, we asked whether siRNA-mediated candidate gene KD affects hiPSC-CM proliferation 1 7 ( Figure 4A ). 23 Indeed, siRNAs directed against all 10 candidate genes together caused a marked concomitant with downregulation of cell cycle genes ( Figure 4F ). In addition, proliferation 2 0 inhibitors (TP53) and apoptosis markers were increased ( Figure 4G ). Subsequently, KD of the 2 1 individual candidates revealed that siAPOB and siLRP2 were each able to recapitulate the In order to determine the impact of APOB and LRP2 during the process of cardiogenesis, 1 both genes were simultaneously knocked down in 5 day old hiPSC-derived cardiac progenitors 2 and cardiac differentiation was assessed at day 12 ( Figure 4N ). Lineage quantification was 3 performed using ACTN1 as a marker of cardiomyocytes, and TAGLN as a marker of fibroblasts. In order to delineate how potentially pathogenic mutations in the proband's six genes melanogaster) ( Figure 5A ; Online Table 5 ). Strikingly, the resulting network (82 genes; Online 1 5 Figure 5 ) connected all 6 genes to WNT and SHH signaling cascades, both key regulators of 1 6 cardiac differentiation and proliferation. 33, 34 Consistent with these findings, RNA-seq analysis of 1 7 the family trio cells reveiled that negative regulator of SHH pathway, PTCH1, was upregulated, suggesting these pathways are attenuated in the proband. In addition, TP53 and CDKN1A 2 0 expression was upregulated in response to siAPOB or siLRP2 ( Figure 4 ), and notably also in To evaluate whether the proband's regulatory network of genes is generalizable to 5 HLHS, we determined the frequency of rare, predicted-damaging variants in these genes in a 6 cohort of 130 HLHS cases and 861 controls. Of the 82 genes, 65 had at least one rare variant 7 present in cases or controls, yet LRP2 was the only gene with significant enrichment in cases 8 (Online Table 6 ). HLHS patients had a ~3-fold increase in the frequency of LRP2 missense 9 variants compared to healthy controls (10% versus 3.4%; p=0.0008). Moreover, among the 13 1 0 patients (including the index case) who carried a LRP2 variant, 4 developed early heart failure 1 1 ( Figure 5B , Online Table 7 ). Comparison of LRP2 variants identified in cases and controls did 1 2 not reveal significant differences in their population-based frequencies, predicted-damaging 1 3 scores, or presence in binding domains (data not shown). Of note, 13 of the 130 HLHS cases LRP2 however all variants assessed were required to be rare in all racial populations. To 1 7 eliminate the potentially confounding variable of race a Caucasian-only sub-analysis was 1 8
performed, resulting in a less significant p-value for rare, predicted-damaging missense variants 1 9
(7.7% versus 3.4%; p=0.05). However, removal of the predicted-damaging restriction on rare 2 0 LRP2 variants among Caucasians revealed significant enrichment in cases (p=0.0035), most 2 1 notably in missense and intronic variants (p=0.0178 and 0.0082, respectively) Online Table 8 ).
2
Location of variants within active histone marks or transcription factor binding sites was not 1 3 different between cases and controls. The biological significance of rare LRP2 variants in HLHS 1 and potential race-specific differences require further study. Unraveling the molecular-genetic etiology of HLHS pathogenesis is crucial for (1) our 6 ability to provide reliable prenatal diagnostics to families and (2) to develop novel approaches to 7 to treat the disease. As an important step towards these goals, our integrated multidisciplinary 8 approach identifies rare variants in LRP2 as a molecular signature enriched in HLHS patients, 9 consistent with our mechanistic analysis in model systems.
1 0
For this study, we used a powerful combination of high-throughput DNA/RNA patient integrated multi-site and multidisciplinary pipeline that systematically evaluates the functional in Donnai-Barrow Syndrome in humans. 36, 37 However, LRP2 has not previously been linked to 2 2 HLHS within curated bioinformatic networks. combinatorially and in sensistized genetic backgrounds (e.g. tinman/NKX2-5). Our current understanding of the molecular genetic causes of HLHS is very limited, been implicated, 1, 3, 4 but they are also associated with other CHDs.
0
Heart development is a complex process that involves the interaction of many pathways Interestingly, the only mouse HLHS model to date, a digenic mutant for sap130 and 6 pcdha9, 5 has a penetrance of less than thirty percent, indicating a profound role for subtle 7 differences between genetic backgrounds. This mouse model suggests a separate mechanism 8 with pcdha9 affecting aortic growth, whereas sap130 can exert a more severe HLHS-like 9 phenotype, which might reflect a modular etiology of HLHS that separates valve and ventricular 1 0
defects.
1
The gene network analysis that we have conducted points to the possibility that several of 1 2 the prioritized candidate genes identified in the index patient can have a modulatory impact on 1 3
WNT and/or SHH via a diverse set of mechanisms. 33 There is evidence that the three of the indeed depends on APOB and LRP2 levels. Such a multi-hit model of HLHS caused by sub-2 0 threshold hypomorphic alleles represents an attractive explanation of the disease. In summary, this integrated multidisciplinary strategy of functional genomics using Azpiazu N and Frasch M. Tinman and bagpipe: two homeo box genes that determine cell fates in 3 the dorsal mesoderm of Drosophila. Genes Dev. 1993; 7:1325 -1340 18.
Bodmer R. The gene tinman is required for specification of the heart and visceral muscles in 5 Drosophila. Development. 1993; 118:719-729 sequencing. An iterative, family-based variant filtering approach based on rarity, functional 2 impact, and mode of inheritance yielded 61 candidate genes. RNA sequencing data from d0 iPSC 3 and d25 differentiated iPSC were used to filter for transcriptional differences yielding 10 4 candidate genes. Figure 5 
